Maria M. G.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of Safety and Efficacy of Debio 0123 and Sacituzumab Govitecan in Advanced/Metastatic Triple-Negative or HR+/HER2- Breast Cancer
- Phase I Study of BI 764532 Dose Tolerability in Patients with DLL3-Positive Glioma
- Phase Ib Dose-Escalation Study of [177Lu]Lu-NeoB with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and as Monotherapy in Recurrent Glioblastoma
Data & Insights
Has run more than one trial at 228 of 447 partner sites.
Specializations
Hepatic Oncology
The investigator specializes in the treatment of intermediate-stage hepatocellular carcinoma, demonstrating expertise in both interventional and systemic therapeutic approaches.
- Liver Cancer Management
- Targeted Cancer Therapies
- Interventional Oncology
Areas of focus include advanced treatment strategies for liver cancer and innovative therapeutic combinations.
Therapeutic Innovation
The investigator works with immunotherapy combinations and vascular-targeted treatments for hepatic malignancies, exploring new therapeutic paradigms.
- Immunotherapy Applications
- Combination Treatments
- Vascular Interventions
Integration of systemic and local therapeutic approaches for optimal patient outcomes.
Clinical Expertise
The investigator has developed proficiency in transarterial therapeutic techniques and systemic cancer treatments for liver malignancies.
- Interventional Procedures
- Advanced Cancer Care
- Treatment Optimization
Expertise in evaluating therapeutic efficacy and safety profiles in hepatic oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.